Yasuyuki Fujita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yasuyuki Fujita has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Susumu Ishikawa
Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo 060-0815, Japan
19 shared publicationsMihoko Kajita
Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan
12 shared publicationsNobuyuki Tanimura
Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan
7 shared publications- Takeshi Maruyama
Department of Medical Sciences, School of Life Sciences, Tokyo University of Pharmacy and Life Science, Tokyo, Japan
7 shared publications Kei Kozawa
Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan
5 shared publicationsKeisuke Kuromiya
Department of Molecular Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University Graduate School of Chemical Sciences and Engineering, Sapporo, Japan
5 shared publications
Latest Publications
- Open Access
- 21 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Filamin–ETV4/5 acts as mechanosensor–mechanotransducer axis that drives cell competition-mediated elimination of transformed cells
Cell competition is a fundamental surveillance mechanism that preserves epithelial integrity by eliminating aberrant "loser" cells through interactions with surrounding "winner" cells. However, how winner cells sense and eliminate transformed neighbours remains poorly understood. Here, using a synNotch-based transcriptomic screen, we identify a mechanosensor-mechanotransducer axis linking the actin crosslinker filamin to the ETV4/5-PRKG2 pathway that mediates extrusion of oncogenically transformed cells through cell competition. Within an epithelial monolayer, transformed cells increase their volume, inducing membrane stretching. In adjacent normal cells, filamin senses the increased membrane tension and triggers activation of ETV4/5. Activated ETV4/5 then upregulate PRKG2, which promotes volume expansion of normal cells, consequently pushing back and driving the extrusion of transformed cells. These findings reveal that dynamic changes in cell volume can trigger mechanotransduction-driven cell competition, uncovering a fundamental pathway by which epithelial tissues maintain homoeostasis and defend against oncogenic transformation.
- 21 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessFilamin–ETV4/5 acts as mechanosensor–mechanotransducer axis that drives cell competition-mediated elimination of transformed cells
Cell competition is a fundamental surveillance mechanism that preserves epithelial integrity by eliminating aberrant "loser" cells through interactions with surrounding "winner" cells. However, how winner cells sense and eliminate transformed neighbours remains poorly understood. Here, using a synNotch-based transcriptomic screen, we identify a mechanosensor-mechanotransducer axis linking the actin crosslinker filamin to the ETV4/5-PRKG2 pathway that mediates extrusion of oncogenically transformed cells through cell competition. Within an epithelial monolayer, transformed cells increase their volume, inducing membrane stretching. In adjacent normal cells, filamin senses the increased membrane tension and triggers activation of ETV4/5. Activated ETV4/5 then upregulate PRKG2, which promotes volume expansion of normal cells, consequently pushing back and driving the extrusion of transformed cells. These findings reveal that dynamic changes in cell volume can trigger mechanotransduction-driven cell competition, uncovering a fundamental pathway by which epithelial tissues maintain homoeostasis and defend against oncogenic transformation.
- 3 April 2024
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 88, 102353
Editorial overview: Navigating the landscapes of mechanobiology and cell–cell interactions
- 3 April 2024
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 88, 102353
Editorial overview: Navigating the landscapes of mechanobiology and cell–cell interactions
- Open Access
- 16 October 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (43)
Accumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cells
In various epithelial tissues, the epithelial monolayer acts as a barrier. To fulfill its function, the structural integrity of the epithelium is tightly controlled. When normal epithelial cells detach from the basal substratum and delaminate into the apical lumen, the apically extruded cells undergo apoptosis, which is termed anoikis. In contrast, transformed cells often become resistant to anoikis and able to survive and grow in the apical luminal space, leading to the formation of multilayered structures, which can be observed at the early stage of carcinogenesis. However, the underlying molecular mechanisms still remain elusive. In this study, we first demonstrate that S100A10 and ANXA2 (Annexin A2) accumulate in apically extruded, transformed cells in both various cell culture systems and murine epithelial tissues in vivo. ANXA2 acts upstream of S100A10 accumulation. Knockdown of ANXA2 promotes apoptosis of apically extruded RasV12-transformed cells and suppresses the formation of multilayered epithelia. In addition, the intracellular reactive oxygen species (ROS) are elevated in apically extruded RasV12 cells. Treatment with ROS scavenger Trolox reduces the occurrence of apoptosis of apically extruded ANXA2-knockdown RasV12 cells and restores the formation of multilayered epithelia. Furthermore, ROS-mediated p38MAPK activation is observed in apically delaminated RasV12 cells, and ANXA2 knockdown further enhances the p38MAPK activity. Moreover, the p38MAPK inhibitor promotes the formation of multilayered epithelia of ANXA2-knockdown RasV12 cells. These results indicate that accumulated ANXA2 diminishes the ROS-mediated p38MAPK activation in apically extruded transformed cells, thereby blocking the induction of apoptosis. Hence, ANXA2 can be a potential therapeutic target to prevent multilayered, precancerous lesions.
- 16 October 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (43)
Open AccessAccumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cells
In various epithelial tissues, the epithelial monolayer acts as a barrier. To fulfill its function, the structural integrity of the epithelium is tightly controlled. When normal epithelial cells detach from the basal substratum and delaminate into the apical lumen, the apically extruded cells undergo apoptosis, which is termed anoikis. In contrast, transformed cells often become resistant to anoikis and able to survive and grow in the apical luminal space, leading to the formation of multilayered structures, which can be observed at the early stage of carcinogenesis. However, the underlying molecular mechanisms still remain elusive. In this study, we first demonstrate that S100A10 and ANXA2 (Annexin A2) accumulate in apically extruded, transformed cells in both various cell culture systems and murine epithelial tissues in vivo. ANXA2 acts upstream of S100A10 accumulation. Knockdown of ANXA2 promotes apoptosis of apically extruded RasV12-transformed cells and suppresses the formation of multilayered epithelia. In addition, the intracellular reactive oxygen species (ROS) are elevated in apically extruded RasV12 cells. Treatment with ROS scavenger Trolox reduces the occurrence of apoptosis of apically extruded ANXA2-knockdown RasV12 cells and restores the formation of multilayered epithelia. Furthermore, ROS-mediated p38MAPK activation is observed in apically delaminated RasV12 cells, and ANXA2 knockdown further enhances the p38MAPK activity. Moreover, the p38MAPK inhibitor promotes the formation of multilayered epithelia of ANXA2-knockdown RasV12 cells. These results indicate that accumulated ANXA2 diminishes the ROS-mediated p38MAPK activation in apically extruded transformed cells, thereby blocking the induction of apoptosis. Hence, ANXA2 can be a potential therapeutic target to prevent multilayered, precancerous lesions.
- Open Access
- 30 August 2022
- Published by Wiley in Cancer Science
- Vol. 113 (11) , 3710-3721
Basal extrusion of single‐oncogenic mutant cells induces dome‐like structures with altered microenvironments
At the initial stage of carcinogenesis, oncogenic transformation occurs in single cells within epithelial layers. However, the behavior and fate of the newly emerging transformed cells remain enigmatic. Here, using originally established mouse models, we investigate the fate of RasV12‐transformed cells that appear in a mosaic manner within epithelial tissues. In the lung bronchial epithelium, most majority of RasV12‐transformed cells are apically extruded, whereas noneliminated RasV12 cells are often basally delaminated leading to various noncell‐autonomous changes in surrounding environments; macrophages and activated fibroblasts are accumulated, and normal epithelial cells overlying RasV12 cells overproliferate and form a convex multilayer, which is termed a ‘dome‐like structure’. In addition, basally extruded RasV12 cells acquire certain features of epithelial–mesenchymal transition (EMT). Furthermore, the expression of COX‐2 is profoundly elevated in RasV12 cells in dome‐like structures, and treatment with the COX inhibitor ibuprofen suppresses the recruitment of activated fibroblasts and moderately diminishes the formation of dome‐like structures. Therefore, basal extrusion of single‐oncogenic mutant cells can induce a tumor microenvironment and EMT and generate characteristic precancerous lesions, providing molecular insights into the earlier steps of cancer development.
- 30 August 2022
- Published by Wiley in Cancer Science
- Vol. 113 (11) , 3710-3721
Open AccessBasal extrusion of single‐oncogenic mutant cells induces dome‐like structures with altered microenvironments
At the initial stage of carcinogenesis, oncogenic transformation occurs in single cells within epithelial layers. However, the behavior and fate of the newly emerging transformed cells remain enigmatic. Here, using originally established mouse models, we investigate the fate of RasV12‐transformed cells that appear in a mosaic manner within epithelial tissues. In the lung bronchial epithelium, most majority of RasV12‐transformed cells are apically extruded, whereas noneliminated RasV12 cells are often basally delaminated leading to various noncell‐autonomous changes in surrounding environments; macrophages and activated fibroblasts are accumulated, and normal epithelial cells overlying RasV12 cells overproliferate and form a convex multilayer, which is termed a ‘dome‐like structure’. In addition, basally extruded RasV12 cells acquire certain features of epithelial–mesenchymal transition (EMT). Furthermore, the expression of COX‐2 is profoundly elevated in RasV12 cells in dome‐like structures, and treatment with the COX inhibitor ibuprofen suppresses the recruitment of activated fibroblasts and moderately diminishes the formation of dome‐like structures. Therefore, basal extrusion of single‐oncogenic mutant cells can induce a tumor microenvironment and EMT and generate characteristic precancerous lesions, providing molecular insights into the earlier steps of cancer development.
- Open Access
- 12 July 2022
- Published by Elsevier in Cell Reports
- Vol. 40 (2) , 111078
Calcium sparks enhance the tissue fluidity within epithelial layers and promote apical extrusion of transformed cells
- 12 July 2022
- Published by Elsevier in Cell Reports
- Vol. 40 (2) , 111078
Open AccessCalcium sparks enhance the tissue fluidity within epithelial layers and promote apical extrusion of transformed cells
- 12 April 2022
- Published by Elsevier in Current Biology
- Vol. 32 (10) , 2144-2159.e5
Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis
- 12 April 2022
- Published by Elsevier in Current Biology
- Vol. 32 (10) , 2144-2159.e5
Extracellular ATP facilitates cell extrusion from epithelial layers mediated by cell competition or apoptosis
- 1 February 2022
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 72, 15-21
Cell competition in vertebrates — a key machinery for tissue homeostasis
- 1 February 2022
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 72, 15-21
Cell competition in vertebrates — a key machinery for tissue homeostasis
- 1 September 2021
- Published by Elsevier in Current Biology
- Vol. 31 (18) , 3984-3995.e5
Sequential oncogenic mutations influence cell competition
- 1 September 2021
- Published by Elsevier in Current Biology
- Vol. 31 (18) , 3984-3995.e5
Sequential oncogenic mutations influence cell competition
- 1 August 2021
- Published by Elsevier in Developmental Biology
- Vol. 476, 112-116
Cell competition-induced apical elimination of transformed cells, EDAC, orchestrates the cellular homeostasis
- 1 August 2021
- Published by Elsevier in Developmental Biology
- Vol. 476, 112-116
Cell competition-induced apical elimination of transformed cells, EDAC, orchestrates the cellular homeostasis
- 1 July 2021
- Published by Elsevier in Current Biology
- Vol. 31 (14) , 3086-3097.e7
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia
- 1 July 2021
- Published by Elsevier in Current Biology
- Vol. 31 (14) , 3086-3097.e7
The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia